NI200700162A - 4-feniltetrahidroisoquinolinas sustituidas, métodos para producirlas, su uso como fármaco y fármaco que las contiene. - Google Patents
4-feniltetrahidroisoquinolinas sustituidas, métodos para producirlas, su uso como fármaco y fármaco que las contiene.Info
- Publication number
- NI200700162A NI200700162A NI200700162A NI200700162A NI200700162A NI 200700162 A NI200700162 A NI 200700162A NI 200700162 A NI200700162 A NI 200700162A NI 200700162 A NI200700162 A NI 200700162A NI 200700162 A NI200700162 A NI 200700162A
- Authority
- NI
- Nicaragua
- Prior art keywords
- drug
- tethrohyrochinolines
- phenyl
- replaced
- production methods
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 208000009304 Acute Kidney Injury Diseases 0.000 abstract 1
- 208000033626 Renal failure acute Diseases 0.000 abstract 1
- 206010041235 Snoring Diseases 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 201000011040 acute kidney failure Diseases 0.000 abstract 1
- 208000012998 acute renal failure Diseases 0.000 abstract 1
- 208000020832 chronic kidney disease Diseases 0.000 abstract 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 abstract 1
- 208000017169 kidney disease Diseases 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 201000002859 sleep apnea Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La invención se refiere a compuestos de fórmula (I) en donde R1 a R8, W, X y Z son cada uno como se definieron en las reivindicaciones. Los medicamentos que comprenden compuestos de este tipo son útiles en la prevención o el tratamiento de diversos trastornos. Por ejemplo, los compuestos se pueden utilizar, inter alia, para trastornos renales, tales como insuficiencia renal aguda o crónica, para trastornos de la función biliar y para trastornos respiratorios, tales como ronquidos o apneas del sueño.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005001411A DE102005001411A1 (de) | 2005-01-12 | 2005-01-12 | Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NI200700162A true NI200700162A (es) | 2008-04-21 |
Family
ID=36121409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NI200700162A NI200700162A (es) | 2005-01-12 | 2007-06-21 | 4-feniltetrahidroisoquinolinas sustituidas, métodos para producirlas, su uso como fármaco y fármaco que las contiene. |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US7868003B2 (es) |
| EP (1) | EP1838315B1 (es) |
| JP (1) | JP2008526906A (es) |
| KR (1) | KR20070094916A (es) |
| CN (1) | CN101184488A (es) |
| AR (1) | AR053326A1 (es) |
| AU (1) | AU2005324833A1 (es) |
| BR (1) | BRPI0519854A2 (es) |
| CA (1) | CA2594419A1 (es) |
| CR (1) | CR9191A (es) |
| DE (1) | DE102005001411A1 (es) |
| DK (1) | DK1838315T3 (es) |
| DO (1) | DOP2006000011A (es) |
| ES (1) | ES2470980T3 (es) |
| GT (1) | GT200600017A (es) |
| IL (1) | IL184314A0 (es) |
| MA (1) | MA29227B1 (es) |
| MX (1) | MX2007008269A (es) |
| MY (1) | MY142493A (es) |
| NI (1) | NI200700162A (es) |
| NO (1) | NO20074084L (es) |
| NZ (1) | NZ556080A (es) |
| PA (1) | PA8659501A1 (es) |
| PT (1) | PT1838315E (es) |
| RU (1) | RU2398766C2 (es) |
| TN (1) | TNSN07263A1 (es) |
| TW (1) | TW200637842A (es) |
| UA (1) | UA88941C2 (es) |
| UY (1) | UY29333A1 (es) |
| WO (1) | WO2006074813A1 (es) |
| ZA (1) | ZA200704728B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2735842A1 (en) * | 2008-09-02 | 2010-03-11 | Sanofi-Aventis | Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
| US10543207B2 (en) * | 2008-12-31 | 2020-01-28 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| KR101683318B1 (ko) * | 2008-12-31 | 2016-12-07 | 알데릭스, 인코포레이티드 | 체액 저류 또는 염 과부하와 연관된 장애 및 위장관 장애의 치료 시에 ｎｈｅ-매개된 역수송을 억제하는 화합물 및 방법 |
| US20120088737A2 (en) * | 2009-10-02 | 2012-04-12 | Ajinomoto Co., Inc | Novel acyl guanidine derivatives |
| ES2575215T3 (es) | 2009-12-11 | 2016-06-27 | Autifony Therapeutics Limited | Derivados de imidazolidindiona |
| WO2012151559A2 (en) * | 2011-05-05 | 2012-11-08 | Rose Pharmaceuticals, Llc | Cytotoxic therapy by proton flux modulation |
| RU2675364C2 (ru) | 2013-04-12 | 2018-12-19 | Арделикс, Инк | Nhe3-связывающие соединения и способы ингибирования транспорта фосфатов |
| CN106536502B (zh) * | 2014-07-25 | 2019-03-05 | 大正制药株式会社 | 被杂芳基取代的苯基四氢异喹啉化合物 |
| JP6903923B2 (ja) * | 2016-01-22 | 2021-07-14 | 大正製薬株式会社 | ヘテロアリールで置換されたフェニルテトラヒドロイソキノリン化合物を有効成分として含有する医薬 |
| US11147884B2 (en) | 2017-01-09 | 2021-10-19 | Ardelyx, Inc. | Inhibitors of NHE-mediated antiport |
| CN118221656A (zh) | 2017-01-09 | 2024-06-21 | 阿德利克斯股份有限公司 | 可用于治疗胃肠道病症的化合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19633966A1 (de) | 1996-08-22 | 1998-02-26 | Hoechst Ag | Phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19945302A1 (de) | 1999-09-22 | 2001-03-29 | Merck Patent Gmbh | Biphenylderivate als NHE-3-Inhibitoren |
| NZ519146A (en) | 1999-11-03 | 2004-02-27 | Albany Molecular Res Inc | 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| DE19960204A1 (de) | 1999-12-14 | 2001-06-28 | Aventis Pharma Gmbh | Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE10015248A1 (de) | 2000-03-28 | 2001-10-04 | Merck Patent Gmbh | Bisamidino-Verbindungen als NHE-3 Inhibitoren |
| DE10019062A1 (de) | 2000-04-18 | 2001-10-25 | Merck Patent Gmbh | 2-Guanidino-4-aryl-chinazoline als NHE-3 Inhibitoren |
| ATE425968T1 (de) * | 2001-12-05 | 2009-04-15 | Sanofi Aventis Deutschland | Substituierte 4-phenyltetrahydroisochinoline, verfahren zu ihrer herstellung, ihre verwendung als medikament, sowie sie enthaltendes medikament |
| DE10163914A1 (de) | 2001-12-22 | 2003-07-03 | Aventis Pharma Gmbh | Substituierte 4-Phenyltetrahydroisochinolinium-Salze, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
| DE10312963A1 (de) * | 2003-03-24 | 2004-10-07 | Aventis Pharma Deutschland Gmbh | Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
-
2005
- 2005-01-12 DE DE102005001411A patent/DE102005001411A1/de not_active Withdrawn
- 2005-12-30 KR KR1020077015974A patent/KR20070094916A/ko not_active Application Discontinuation
- 2005-12-30 EP EP05823573.0A patent/EP1838315B1/de active Active
- 2005-12-30 DK DK05823573.0T patent/DK1838315T3/da active
- 2005-12-30 ES ES05823573.0T patent/ES2470980T3/es active Active
- 2005-12-30 BR BRPI0519854-2A patent/BRPI0519854A2/pt not_active IP Right Cessation
- 2005-12-30 CN CNA2005800465296A patent/CN101184488A/zh active Pending
- 2005-12-30 PT PT58235730T patent/PT1838315E/pt unknown
- 2005-12-30 UA UAA200709180A patent/UA88941C2/ru unknown
- 2005-12-30 AU AU2005324833A patent/AU2005324833A1/en not_active Abandoned
- 2005-12-30 WO PCT/EP2005/014127 patent/WO2006074813A1/de active Application Filing
- 2005-12-30 MX MX2007008269A patent/MX2007008269A/es active IP Right Grant
- 2005-12-30 RU RU2007130706/04A patent/RU2398766C2/ru not_active IP Right Cessation
- 2005-12-30 JP JP2007550712A patent/JP2008526906A/ja not_active Abandoned
- 2005-12-30 NZ NZ556080A patent/NZ556080A/en not_active IP Right Cessation
- 2005-12-30 CA CA002594419A patent/CA2594419A1/en not_active Abandoned
-
2006
- 2006-01-10 AR ARP060100092A patent/AR053326A1/es not_active Application Discontinuation
- 2006-01-10 TW TW095100824A patent/TW200637842A/zh unknown
- 2006-01-11 GT GT200600017A patent/GT200600017A/es unknown
- 2006-01-11 MY MYPI20060103A patent/MY142493A/en unknown
- 2006-01-11 PA PA20068659501A patent/PA8659501A1/es unknown
- 2006-01-12 UY UY29333A patent/UY29333A1/es unknown
- 2006-01-12 DO DO2006000011A patent/DOP2006000011A/es unknown
-
2007
- 2007-06-14 ZA ZA200704728A patent/ZA200704728B/en unknown
- 2007-06-19 CR CR9191A patent/CR9191A/es not_active Application Discontinuation
- 2007-06-21 NI NI200700162A patent/NI200700162A/es unknown
- 2007-07-01 IL IL184314A patent/IL184314A0/en unknown
- 2007-07-06 MA MA30050A patent/MA29227B1/fr unknown
- 2007-07-11 US US11/776,041 patent/US7868003B2/en not_active Expired - Fee Related
- 2007-07-11 TN TNP2007000263A patent/TNSN07263A1/en unknown
- 2007-08-07 NO NO20074084A patent/NO20074084L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| UY29333A1 (es) | 2006-08-31 |
| RU2007130706A (ru) | 2009-02-20 |
| DK1838315T3 (da) | 2014-06-16 |
| IL184314A0 (en) | 2007-10-31 |
| US20080058328A1 (en) | 2008-03-06 |
| AU2005324833A1 (en) | 2006-07-20 |
| AR053326A1 (es) | 2007-05-02 |
| BRPI0519854A2 (pt) | 2009-03-24 |
| WO2006074813A1 (de) | 2006-07-20 |
| MY142493A (en) | 2010-11-30 |
| PT1838315E (pt) | 2014-05-26 |
| US7868003B2 (en) | 2011-01-11 |
| PA8659501A1 (es) | 2006-09-08 |
| UA88941C2 (ru) | 2009-12-10 |
| NZ556080A (en) | 2009-08-28 |
| CR9191A (es) | 2007-10-04 |
| MA29227B1 (fr) | 2008-02-01 |
| RU2398766C2 (ru) | 2010-09-10 |
| MX2007008269A (es) | 2008-01-16 |
| TNSN07263A1 (en) | 2008-12-31 |
| EP1838315A1 (de) | 2007-10-03 |
| KR20070094916A (ko) | 2007-09-27 |
| CN101184488A (zh) | 2008-05-21 |
| ZA200704728B (en) | 2008-07-30 |
| ES2470980T3 (es) | 2014-06-24 |
| DE102005001411A1 (de) | 2006-07-27 |
| EP1838315B1 (de) | 2014-03-12 |
| GT200600017A (es) | 2006-08-28 |
| JP2008526906A (ja) | 2008-07-24 |
| NO20074084L (no) | 2007-09-28 |
| TW200637842A (en) | 2006-11-01 |
| CA2594419A1 (en) | 2006-07-20 |
| DOP2006000011A (es) | 2006-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NI200700162A (es) | 4-feniltetrahidroisoquinolinas sustituidas, métodos para producirlas, su uso como fármaco y fármaco que las contiene. | |
| CR20120332A (es) | Derivados de pirazina y su uso en el tratamiento de trastornos neurológicos. | |
| CO6491058A2 (es) | Derivados de oxazina y su uso como inhibidores de bace para el tratamiento de trastornos neurológicos | |
| BR112013028666A2 (pt) | compostos de pirazolo sulfonamida tricícilos e métodos para fazer e usar o mesmo | |
| ECSP088283A (es) | Compuestos de piridina 5- (fenilisoxazoliletoxi) -triazol- 3-ilo substituidos para el tratamiento de trastornos neurológicos, psiquiátricos o del dolor | |
| PA8841201A1 (es) | Aminoindanos sustituidos y sus análogos, y el uso farmacéutico de los mismos | |
| UY31053A1 (es) | Derivados heterociclicos, procesos para su produccion, medicamentos que comprende estos compuestos y su uso | |
| ECSP088358A (es) | Tratamiento y profilaxis de microangiopatías | |
| ECSP088774A (es) | Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmacéuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricación. | |
| CR9667A (es) | Derivados de benzamida y usos relacionados con los mismos | |
| PA8720801A1 (es) | Nuevas combinaciones terapeuticas para el tratamiento de la depresion | |
| NI201100117A (es) | Antagonistas de 4 -- azetidinil - 1 - heteroaril - ciclohexanol del ccr2. | |
| NO20084328L (no) | Nye forbindelser | |
| AR071120A1 (es) | Derivados de diosmetina, su procedimiento de preparacion, las composiciones farmaceuticas que los contienen y su uso en el tratamiento de las enfermedades venosas cronicas. | |
| UY31645A1 (es) | Nuevas imidazolidinas fenil-sustituidas, procedimiento para su preparación, medicamentos que conprenden dichos compuestos y su uso. | |
| UY30577A1 (es) | Derivados de éter diarilico y usos de los mismos | |
| TW200510321A (en) | Substituted 4-phenyltetrahydroisoquinolines, process for preparing them, their use as a medicament, and medicament comprising them | |
| UY28726A1 (es) | N-ciclohexilimidazolinonas sustituidas.procedimientos para su preparación y su uso como medicamentos. | |
| ATE526967T1 (de) | Medikamente für inhalationen enthaltend ein anticholinergikum und ein betamimetikum | |
| TN2010000266A1 (en) | Oxazolidinones for the treatment and/or prophylaxis of heart failure | |
| MX2009005912A (es) | Derivados de etilamina-fenilo heterociclilo sustituidos, su preparacion y uso como medicamentos. | |
| UY30217A1 (es) | 1-amino-4-fenildihidroisoquinolinas sustituidas, procedimiento para su preparacion, su uso como medicamento, y medicamento que las comprende. | |
| DK1511466T3 (da) | Anvendelse af glycosaminoglycaner, såsom for eksempel heparin, til behandling af respirationslidelser, såsom COPD | |
| UY30218A1 (es) | 2-amino-4-fenildihidroquinolinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento y medicamentos que las comprenden | |
| TW200508206A (en) | Novel substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aid, and medicament containing them |